In the US, Amoclan (amoxicillin/clavulanate systemic) is a member of the drug class beta-lactamase inhibitors and is used to treat Aspiration Pneumonia, Bacterial Infection, Bronchitis, Febrile Neutropenia, Kidney Infections, Melioidosis, Otitis Media, Pneumonia, Sinusitis, Skin and Structure Infection, Skin Infection, Small Bowel Bacterial Overgrowth, Strep Throat, Upper Respiratory Tract Infection and Urinary Tract Infection.
US matches:
- Amoclan Suspension
- Amoclan
Ingredient matches for Amoclan
Amoxicillin
Amoxicillin is reported as an ingredient of Amoclan in the following countries:
- Bahrain
- Egypt
- Iraq
- Jordan
- Kuwait
- Lebanon
- Libya
- Oman
- Poland
- Qatar
- Saudi Arabia
- South Africa
- Sudan
- Syria
- Tunisia
- United Arab Emirates
- Yemen
Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoclan in the following countries:
- Bahrain
- Egypt
- Iraq
- Jordan
- Kuwait
- Lebanon
- Libya
- Netherlands
- Oman
- Qatar
- Saudi Arabia
- Sudan
- Syria
- United Arab Emirates
- Yemen
Clavulanate
Clavulanic Acid is reported as an ingredient of Amoclan in the following countries:
- Bahrain
- Egypt
- Iraq
- Jordan
- Kuwait
- Lebanon
- Libya
- Oman
- Poland
- Qatar
- Saudi Arabia
- South Africa
- Sudan
- Syria
- Tunisia
- United Arab Emirates
- Yemen
Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoclan in the following countries:
- Bahrain
- Egypt
- Iraq
- Jordan
- Kuwait
- Lebanon
- Libya
- Netherlands
- Oman
- Qatar
- Saudi Arabia
- Sudan
- Syria
- United Arab Emirates
- Yemen
International Drug Name Search